Nantong JiangTian Chemical Co., Ltd.

SZSE:300927.SZ

15.96 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 350.42166.538169.505179.899171.299179.503169.265168.855191.495185.946174.176184.349192.824192.198169.266176.438172.073127.95298.713105.579105.462126.913113.82
Cost of Revenue 331.467140.325145.613154.202142.625147.142136.825135.185147.471161.172144.867150.607148.095149.146139.773138.965134.209110.38468.2766.40482.87557.610
Gross Profit 18.95326.21323.89225.69728.67432.36132.44133.6744.02424.77429.30933.74244.72943.05229.49337.47437.86317.56830.44339.17522.58769.303113.82
Gross Profit Ratio 0.0540.1570.1410.1430.1670.180.1920.1990.230.1330.1680.1830.2320.2240.1740.2120.220.1370.3080.3710.2140.5461
Reseach & Development Expenses 1.6611.5131.1681.0811.2222.8691.6791.7751.6791.4921.7511.7591.3921.7761.9181.7141.4552.4551.4651.9861.13818.9830
General & Administrative Expenses 10.172-5.98818.341-2.1736.738-10.94615.995-0.5647.2194.05721.963-3.6588.771-13.25819.541-2.2557.8873.04910.024-7.8744.6120.6170
Selling & Marketing Expenses 6.162-5.3997.1853.0032.9683.0662.9833.1982.7553.3782.622.5072.4143.1122.1532.4482.267-10.7086.60510.9640.9928.9990
SG&A 16.334-11.38625.52610.1439.706-7.8818.9782.6349.9747.90324.584-1.15111.185-10.14621.6940.19310.154-7.65916.6283.0895.648.9710
Other Expenses -0.83224.401-14.305-0.8870.004-0.1480.0650.01-0.014-0.281-0.004-0.0980.004-0.002-0.2070.0151.865-0.011-1.4122.8680.995-118.601-97.432
Operating Expenses 17.16314.52812.38911.22412.01214.50112.22415.1412.739.11414.95513.74113.43416.89213.34114.04712.0051.09215.13919.737.538-118.601-97.432
Operating Income 1.7911.68511.50314.47316.46218.31819.42621.38130.2615.6614.99820.57531.55223.79616.45822.63323.57614.0114.81218.89414.0478.31316.388
Operating Income Ratio 0.0050.070.0680.080.0960.1020.1150.1270.1580.0840.0860.1120.1640.1240.0970.1280.1370.1090.150.1790.1330.0650.144
Total Other Income Expenses Net 0.201255.1170.0081.8520.004-0.1060.0650.01-0.014-0.12-0.004-0.0980.004-0.014-0.2070.0151.865-0.0110.0031.4530.9951.910.002
Income Before Tax 1.991266.80211.51216.32516.46618.21319.49121.3930.24715.5414.99420.47731.55723.78216.25122.64725.44113.99814.81520.34715.04210.22316.39
Income Before Tax Ratio 0.0061.6020.0680.0910.0960.1010.1150.1270.1580.0840.0860.1110.1640.1240.0960.1280.1480.1090.150.1930.1430.0810.144
Income Tax Expense 1.1723.0562.6263.6684.023.6184.8124.9397.4252.5523.7974.6287.7962.6052.4673.3733.8511.472.3283.1122.2881.0562.404
Net Income 0.819263.7468.88612.65712.44614.59414.67916.45222.82212.98811.19615.84923.76121.17813.78419.27421.5912.52812.48717.23612.7549.16713.987
Net Income Ratio 0.0021.5840.0520.070.0730.0810.0870.0970.1190.070.0640.0860.1230.110.0810.1090.1250.0980.1270.1630.1210.0720.123
EPS 0.0061.8320.0620.0880.0860.10.10.110.160.090.0780.110.160.150.0960.130.150.120.120.160.120.0850
EPS Diluted 0.0061.8320.0620.0880.0860.10.10.110.160.090.0780.110.160.150.0960.130.150.120.120.160.120.0850
EBITDA 2.443266.29213.1225.38825.45528.57129.93730.9440.16722.79724.72730.49541.52433.24826.14532.51935.92818.94319.28223.78420.254-297.053113.82
EBITDA Ratio 0.0071.5990.0770.1410.1490.1590.1770.1830.210.1230.1420.1650.2150.1730.1540.1840.2090.1480.1950.2250.192-2.3411